The School is aimed at graduate students and young scientists who are starting, or in the early stages of a career in virology, public health, surveillance, research or product development. The scientific programme is an intensive day before the start of the Options meeting with presentations to provide participants with a comprehensive scientific grounding in many aspects of influenza, RSV and SARS-CoV-2 ranging from theoretical concepts to basic techniques used in research and surveillance. The course is designed for a minimum of 30 students and around 80 students are expected.
Programme
8.00-8.30 Registration
8.30 Welcome to School - Rebecca Cox, Mark Tompkins, Kirsty Short
EPIDEMIOLOGY: Chair Kirsty Short
08.35-09.15 Influenza (past and present) - Rebecca Cox Ph.D.
09.15-9.55 RSV and SARS-CoV-2 - Kirsten Spann Ph.D. University of Queensland, Australia
VIROLOGY AND ECOLOGY: Chair Mark Tompkins
10.00- 10.40 Influenza at human interface/One Health - Erik Karlsson Ph.D.
10.40-11.10 Coffee
11.10-11.50 Virus structure, replication - Erik Karlsson Ph.D.
PREVENTION AND CONTROL: ANTIVIRALS: Chair Mike Ison
11.50-12.30 Antiviral Update - Emi Takashita Ph.D.
12.30 to 13.00 Antiviral resistance - Cameron Wolfe M.B.B.S.
13.00-14:00 Lunch
PREVENTION AND CONTROL: IMMUNOLOGY: Chair Rebecca Cox
14:00-14.40 Immunity to respiratory viruses and correlates of protection Chris Chiu MBBChir. Ph.D.
PREVENTION AND CONTROL: VACCINES: Chair Rebecca Cox
14.40-15.20 Influenza vaccines, effectiveness and study design - Sheena Sullivan Ph.D.
15.20-15.50 Next generation "universal" vaccines and future perspectives on influenza and SARS CoV-2 - Florian Krammer Ph.D.
15.50-16.30 Tour of lab and coffee
16.30 Future perspectives on respiratory viruses - Maria Zambon MBBChr. Ph.D.
17.15 Close of School - Rebecca Cox
